Download MendeleyMethotrexate recognition by the human reduced folate carrier SLC19A1.
Wright, N.J., Fedor, J.G., Zhang, H., Jeong, P., Suo, Y., Yoo, J., Hong, J., Im, W., Lee, S.Y.(2022) Nature 609: 1056-1062
- PubMed: 36071163
- DOI: https://doi.org/10.1038/s41586-022-05168-0
- Primary Citation of Related Structures:
7TX6, 7TX7, 8DEP - PubMed Abstract:
Folates are essential nutrients with important roles as cofactors in one-carbon transfer reactions, being heavily utilized in the synthesis of nucleic acids and the metabolism of amino acids during cell division 1,2 . Mammals lack de novo folate synthesis pathways and thus rely on folate uptake from the extracellular milieu 3 . The human reduced folate carrier (hRFC, also known as SLC19A1) is the major importer of folates into the cell 1,3 , as well as chemotherapeutic agents such as methotrexate 4-6 . As an anion exchanger, RFC couples the import of folates and antifolates to anion export across the cell membrane and it is a major determinant in methotrexate (antifolate) sensitivity, as genetic variants and its depletion result in drug resistance 4-8 . Despite its importance, the molecular basis of substrate specificity by hRFC remains unclear. Here we present cryo-electron microscopy structures of hRFC in the apo state and captured in complex with methotrexate. Combined with molecular dynamics simulations and functional experiments, our study uncovers key determinants of hRFC transport selectivity among folates and antifolate drugs while shedding light on important features of anion recognition by hRFC.
Organizational Affiliation:
Department of Biochemistry, Duke University School of Medicine, Durham, NC, USA.
